BuzzSparks.org

Tokai Pharmaceuticals


hormone-dependent growth disorders

Tokai was founded by Apple Tree Partners to in-license and develop endocrine-based therapies for major diseases. The company’s primary focus is on its proprietary Specific Androgen Receptor Modulator/Lyase Inhibitor (TOK-001) for Castration...

Homepage:
Total money raised: $100.5M

Tokai Pharmaceuticals

02142 One Broadway
11th floor

Cambridge
Cambridge
USA MA

Phone: 6172254305

Updated on May 27, 2013
Tokai Pharmaceuticals at CrunchBase
Jodie Morrison CEO
Seth Harrison Board of Directors
Past
Martin D. Williams President and CEO

May, 2013

Tokai Pharmaceuticals raised $35.5M in a Series E round from Apple Tree Partners and Novartis Venture Fund

Tokai lands $35M venture round for triple-threat prostate cancer drug    fiercebiotech.com

Tokai Pharmaceuticals raised $20M in partial round

SEC    sec.gov

September, 2011

Tokai Pharmaceuticals raised $23M in a Series D round from Novartis Venture Fund and Apple Tree Partners

Tokai Pharmaceuticals Raises $23 Million in Funding    eon.businesswire.com

June, 2009

Tokai Pharmaceuticals raised $22M in a Series D round from Apple Tree Partners and Novartis Venture Fund

Tokai Pharmaceuticals, Inc.: Series D $22M    onbiovc.com